ES2082894T3 - Dihidropirido(4,3-d)pirimidinas 4-sustituidas como analgesicos y agentes antiinflamatorios topicos para el tratamiento de enfermedades de la piel. - Google Patents

Dihidropirido(4,3-d)pirimidinas 4-sustituidas como analgesicos y agentes antiinflamatorios topicos para el tratamiento de enfermedades de la piel.

Info

Publication number
ES2082894T3
ES2082894T3 ES91114330T ES91114330T ES2082894T3 ES 2082894 T3 ES2082894 T3 ES 2082894T3 ES 91114330 T ES91114330 T ES 91114330T ES 91114330 T ES91114330 T ES 91114330T ES 2082894 T3 ES2082894 T3 ES 2082894T3
Authority
ES
Spain
Prior art keywords
analgesics
treatment
inflammatory agents
skin diseases
pirimidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91114330T
Other languages
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2082894T3 publication Critical patent/ES2082894T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

SE DESCRIBEN COMPUESTOS QUE TIENEN LA FORMULA DONDE R SUB 1 ES HIDROGENO, ALQUILO INFERIOR, ARILALQUILO INFERIOR O ARILO ; R SUB 2, CUANDO SE ENCUENTRA PRESENTE, ES HIDROGENO, ALQUILO INFERIOR, ARILALQUILO INFERIOR; Y R SUB 3 ES HIDROGENO, ALQUILO INFERIOR, CICLOALQUILO O ARILO; LOS CUALES SON UTILES COMO ANALGESICOS Y COMO AGENTES ANTIINFLAMATORIOS DE USO TOPICO PARA EL TRATAMIENTO DE ENFERMEDADES CUTANEAS.
ES91114330T 1990-08-27 1991-08-27 Dihidropirido(4,3-d)pirimidinas 4-sustituidas como analgesicos y agentes antiinflamatorios topicos para el tratamiento de enfermedades de la piel. Expired - Lifetime ES2082894T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/573,414 US5059602A (en) 1990-08-27 1990-08-27 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders

Publications (1)

Publication Number Publication Date
ES2082894T3 true ES2082894T3 (es) 1996-04-01

Family

ID=24291905

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91114330T Expired - Lifetime ES2082894T3 (es) 1990-08-27 1991-08-27 Dihidropirido(4,3-d)pirimidinas 4-sustituidas como analgesicos y agentes antiinflamatorios topicos para el tratamiento de enfermedades de la piel.

Country Status (22)

Country Link
US (1) US5059602A (es)
EP (1) EP0480155B1 (es)
JP (1) JP3083180B2 (es)
KR (1) KR100218562B1 (es)
AT (1) ATE133670T1 (es)
AU (1) AU635150B2 (es)
CA (1) CA2049850C (es)
CZ (1) CZ280569B6 (es)
DE (1) DE69116788T2 (es)
DK (1) DK0480155T3 (es)
ES (1) ES2082894T3 (es)
FI (1) FI914007L (es)
GR (1) GR3019085T3 (es)
HU (1) HUT59923A (es)
IE (1) IE72086B1 (es)
IL (1) IL99305A (es)
NO (1) NO913331L (es)
NZ (1) NZ239516A (es)
PT (1) PT98773B (es)
SG (1) SG48250A1 (es)
YU (1) YU144391A (es)
ZA (1) ZA916738B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095019A (en) * 1990-08-27 1992-03-10 Hoechst-Roussel Pharmaceuticals Inc. 4-substituted dihydropyrido(4,3-D)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
US6008361A (en) * 1996-04-09 1999-12-28 Pfizer Inc. Substituted pyridines
US6031105A (en) * 1996-04-09 2000-02-29 Pfizer Inc Substituted pyridines
AU2001263239A1 (en) 2000-05-18 2001-11-26 Nuvasive, Inc. Tissue discrimination and applications in medical procedures
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
DK1879877T3 (da) * 2005-05-03 2013-04-15 Ranbaxy Lab Ltd Antimikrobielle midler
JP2009533315A (ja) * 2006-04-10 2009-09-17 ランバクシー ラボラトリーズ リミテッド 抗菌剤
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1197466B (de) * 1962-03-22 1965-07-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 5, 6, 7, 8-Tetrahydropyrido-[4, 3-d]pyrimidinen
US3635973A (en) * 1969-11-20 1972-01-18 Sherwin Williams Co Method of preparing 3-substituted pyridopyrimidinediones and lumazines
US3962264A (en) * 1972-09-27 1976-06-08 Pfizer Inc. Process for making 2-amino nicotinonitrile
DE3438351A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3502590A1 (de) * 1985-01-26 1986-07-31 Gödecke AG, 1000 Berlin 5-alkoxy-pyrido(4,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3502742A1 (de) * 1985-01-28 1986-07-31 Gödecke AG, 1000 Berlin 5-oxo-pyrido(4,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
CZ280569B6 (cs) 1996-02-14
PT98773B (pt) 1999-01-29
PT98773A (pt) 1992-07-31
IL99305A0 (en) 1992-07-15
YU144391A (sh) 1995-03-27
HUT59923A (en) 1992-07-28
KR920004387A (ko) 1992-03-27
FI914007A7 (fi) 1992-02-28
ATE133670T1 (de) 1996-02-15
ZA916738B (en) 1992-04-29
DE69116788T2 (de) 1996-07-18
IE72086B1 (en) 1997-03-12
AU8271991A (en) 1992-03-05
KR100218562B1 (ko) 1999-09-01
CA2049850A1 (en) 1992-02-28
GR3019085T3 (en) 1996-05-31
SG48250A1 (en) 1998-04-17
JPH04230684A (ja) 1992-08-19
JP3083180B2 (ja) 2000-09-04
FI914007A0 (fi) 1991-08-23
EP0480155A3 (en) 1992-04-29
CS262491A3 (en) 1992-06-17
DE69116788D1 (de) 1996-03-14
AU635150B2 (en) 1993-03-11
IL99305A (en) 1997-02-18
US5059602A (en) 1991-10-22
CA2049850C (en) 2002-03-05
IE913010A1 (en) 1992-03-11
NO913331L (no) 1992-02-28
NZ239516A (en) 1994-04-27
DK0480155T3 (da) 1996-06-10
NO913331D0 (no) 1991-08-26
EP0480155B1 (en) 1996-01-31
FI914007L (fi) 1992-02-28
EP0480155A2 (en) 1992-04-15
HU912786D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
ECSP941135A (es) Antagonistas triciclicos de vasopresina de benzacepina
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2196072T3 (es) Empleo de compuestos heterociclicos como ligandos de dopamina-d3.
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ES2138622T3 (es) Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
ES2164088T3 (es) Antagonistas de la sustancia p para el tratamiento de la emesis.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
PE20010328A1 (es) Analogos de vitamina d3
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
ES2093944T3 (es) Composicion cosmetica y/o dermatologica de accion despigmentante que contiene un acido di- o tri-cafeoilquinico o una mezcla de estos.
NO913331L (no) 4-substituerte dihydropyrido(4,3-d)pyrimidiner for behandling av hudforstyrrelser.
GT199500039A (es) Compuestos ariltios
AR021094A1 (es) Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias
UY26498A1 (es) Pirroles sustituidos
ES2032797T3 (es) Agente terapeutico para el tratamiento de la enfermedad ulcera peptica.
ES2092112T3 (es) Agentes hipoglicemicos de tiazolidindiona.
ES2108298T3 (es) 4-estrenos puenteados en 19,11, activos como gestagenos.
MX9204194A (es) Los compuestos de 1,2,4-oxadiazolil-fenoxialquilisoxazolas y su uso como agentes antivirales
ES2118818T3 (es) Tiazolin-2-onas aminoalquil-substituidas, su obtencion y empleo.
ES2113851T3 (es) Sales cristalinas estables y muy hidrosolubles antivirales de 2',3'-didesoxiinoxina monohidrato, 2',3'-didesoxi-2',3'-didehidrotimidina monohidrato y 2',3'-didesoxi-2'-fluoroinosina hemihidrato.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 480155

Country of ref document: ES